Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07284966 · ClinicalTrials.gov registry record
Comfort and Vision With TOTAL30 Multifocal Lenses
A clinical trial of Myopia and Presbyopia, sponsored by Scripps Poway Eyecare and Optometry.
- Recruiting
- Registry status
- 36
- Enrollment target
- 1
- Study location
NCT07284966: Recruiting study of Myopia and Presbyopia, sponsored by Scripps Poway Eyecare and Optometry.
NCT07284966 is a study of Myopia and Presbyopia that is actively recruiting participants, run by Scripps Poway Eyecare and Optometry. The registered enrollment target is 36 participants, below the 268-participant average among 90 other Myopia trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07284966, a study of Myopia and Presbyopia, is actively recruiting participants, sponsored by Scripps Poway Eyecare and Optometry.
- RECRUITING
- Registry status
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a single-arm, prospective, observational study conducted at one site to evaluate the comfort and vision of the TOTAL30 Multifocal (T30MF) contact lenses over the course of long wear days. The study will assess the proportion of positive subjective Visual Analog Scale (VAS) assessments of comfort and vision at 10, 12, 14, and 16 hours of wear on Days 1, 7, 14, and 30. Additionally, the study will explore subjective assessments of lens comfort using the CLDEQ-8 survey and measure logMAR visual acuity at both distance and near at Visit 1, Visit 2, and after 1 month of lens wear. Participants will undergo three site visits, with at-home surveys conducted at specified intervals to gather real-time data on comfort and vision.
Primary Outcome
Comfort level assessed using real-time patient-reported data collected at multiple time points throughout the day, with a focus on the end of the wear period. Patients are asked "What is your impression of the COMFORT of these study lenses?" and provide and answer from -50 (Extremely uncomfortable) to +50 (Extremely comfortable) using a sliding digital scale.
Conditions Studied
Interventions
- DEVICE TOTAL30 Multifocal
Study Locations (1)
California
- Scripps Optometric Group - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2026-02-05 |
| Est. Completion | 2027-01-21 |
What NCT07284966 shows while recruiting
NCT07284966 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 268-participant average among 90 other Myopia trials with a reported enrollment target (87% lower).
The record links to 3 conditions, with Myopia appearing as the primary indexed condition, and to 1 intervention - of which TOTAL30 Multifocal is the first listed.
NCT07284966 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07284966 about?
NCT07284966 is a clinical study titled "Comfort and Vision With TOTAL30 Multifocal Lenses". This study is a single-arm, prospective, observational study conducted at one site to evaluate the comfort and vision of the TOTAL30 Multifocal (T30MF) contact lenses over the course of long wear days. The study will assess the proportion of positive subjective Visual Analog Scale (VAS) assessments ...
What is the current status of trial NCT07284966?
This trial is currently recruiting. The enrollment target is 36 participants. The study started on 2026-02-05. Estimated completion is 2027-01-21.
What conditions does trial NCT07284966 study?
This clinical trial studies the following conditions: Myopia, Presbyopia, Astigmatism.
What interventions are being tested in trial NCT07284966?
The interventions under investigation include: TOTAL30 Multifocal (DEVICE).
Who is sponsoring clinical trial NCT07284966?
This trial is sponsored by Scripps Poway Eyecare and Optometry, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07284966 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07284966's enrollment target sits among peer trials
36 80th of 90 higher than 11 of 90 other Myopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
RECRUITING · NA
-
Comprehensive Assessment of Multiple Products (CAMP)
RECRUITING · NA
-
Children's Viewing Behavior
RECRUITING · NA
-
Clinical Evaluation of WaveLight Plus LASIK
RECRUITING
-
Violet Light for the Suppression of Myopia
RECRUITING · NA
-
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI